Education
About Us
Working with TipRanks
Follow Us
AbCellera Biologics (ABCL)
NASDAQ:ABCL
AbCellera Biologics (ABCL) Ownership Overview
43.24% Insiders
2.88% Mutual Funds
24.53% Other Institutional Investors
1.11% ETFs
28.24% Public Companies and
Individual Investors
The ownership structure of AbCellera Biologics (ABCL) stock is a mix of institutional, retail, and individual investors. Approximately 28.52% of the company’s stock is owned by Institutional Investors, 43.24% is owned by Insiders, and 28.24% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 11, 2025 | Thermopylae Holdings Ltd. >10% Owner | xxxxxxxxxxxxx | $742243 |
| Mar 10, 2025 | John S. Montalbano Director | xxxxxxxxxxxxx | $57500 |
| Mar 07, 2025 | John S. Montalbano Director | xxxxxxxxxxxxx | $140400 |
| Aug 29, 2024 | Thermopylae Holdings Ltd. >10% Owner | xxxxxxxxxxxxx | $739977 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $303577 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $494238 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 60,740,524 | Insider | 20.60% | 153,066,120 | |
| 56,143,640 | Insider | 18.84% | 141,481,973 | |
| 27,525,640 | Institution | 9.24% | 69,364,613 | |
| 9,613,674 | Insider | 3.23% | 24,226,458 | |
| 7,540,013 | Institution | 2.53% | 19,000,833 | |
| 2,419,603 | Institution | 0.81% | 6,097,400 | |
| 1,441,642 | Insider | 0.48% | 3,632,938 | |
| 601,505 | Institution | 0.20% | 1,515,793 | |
| 429,444 | Institution | 0.14% | 1,082,199 | |
| 363,294 | Institution | 0.12% | 915,501 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,540,013 | Institution | 2.53% | 19,000,833 | |
| 429,444 | Institution | 0.14% | 1,082,199 | |
| 363,294 | Institution | 0.12% | 915,501 | |
| 108,864 | Institution | 0.04% | 274,337 | |
| 58,472 | Institution | 0.02% | 147,349 | |
| 50,000 | Institution | 0.02% | 126,000 | |
| 29,481 | Institution | <0.01% | 74,292 | |
| 9,145 | Institution | <0.01% | 23,045 | |
| 5,132 | Institution | <0.01% | 12,933 | |
| 3 | Institution | <0.01% | 8 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,348,097 | Institution | 0.45% | 3,397,204 | |
| 462,170 | Institution | 0.16% | 1,109,208 | |
| 382,583 | Institution | 0.13% | 918,199 | |
| 145,812 | Institution | 0.05% | 349,949 | |
| 139,335 | Institution | 0.05% | 334,404 | |
| 115,391 | Institution | 0.04% | 276,938 | |
| 64,811 | Institution | 0.02% | 163,324 | |
| 42,708 | Institution | 0.01% | 107,624 | |
| 27,612 | Institution | <0.01% | 69,582 | |
| 11,829 | Institution | <0.01% | 29,809 |
FAQ
Who Owns AbCellera Biologics (ABCL)?
According to the latest TipRanks data, approximately 24.53% of the company's stock is held by institutional investors, 43.24% is held by insiders, and 28.24% is held by retail investors.
What percentage of AbCellera Biologics (ABCL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.53% of AbCellera Biologics (ABCL) stock is held by institutional investors.
What percentage of AbCellera Biologics (ABCL) stock is held by retail investors?
According to the latest TipRanks data, approximately 28.24% of AbCellera Biologics (ABCL) stock is held by retail investors.
Who owns the most shares of AbCellera Biologics (ABCL)?
Carl L.G. Hansen owns the most shares of AbCellera Biologics (ABCL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.